Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

01.12.16	Pfizer Reports Positive Results From LYRICA Study In Pediatric Epilepsy Patients (RTTNews)
01.12.16	It's All Green For BLUE, HTBX Plunges On Failed Study, Watch Out For BPMC (RTTNews)
30.11.16	Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software (PR Newswire)
30.11.16	Pfizer: PF-05280014 Versus Herceptin Study Meets Primary Endpoint (RTTNews)
30.11.16	Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq (RTTNews)
30.11.16	Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq (RTTNews)
29.11.16	Pfizer : FDA Accepts BLA For Avelumab For Treatment Of MMCC For Priority Review (RTTNews)
29.11.16	FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review (PR Newswire)
29.11.16	FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review (PR Newswire)
28.11.16	Innovative Clinical Trial Implementation and Manufacturing Capacity Production Fueling Biotech Sector Growth (PR Newswire)
15.11.16	Pfizer Says Phase 3 OPAL Studies For Xeljanz Met Primary Efficacy Endpoints (RTTNews)
11.11.16	Pfizer: Prevenar 13 To Be Available At Lowest Price For Humanitarian Emergencies (RTTNews)
10.11.16	IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer (Businesswire)
07.11.16	Six Late Stage Drugs That Bit The Dust Recently (RTTNews)
02.11.16	PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA (RTTNews)
01.11.16	Pfizer Q3 Profit Falls; To Discontinue Bococizumab Development Program (RTTNews)
01.11.16	EARNINGS SUMMARY: Details of Pfizer Inc. Q3 Earnings Report (RTTNews)
31.10.16	EMA To Review Merck's Avelumab For Treatment Of Metastatic Merkel Cell Carcinoma (RTTNews)
19.10.16	Pfizer Awarded Grant From Bill & Melinda Gates Foundation - Quick Facts (RTTNews)
18.10.16	Pfizer To Begin Shipment Of Biosimilar INFLECTRA To Wholesalers In Nov (RTTNews)
15.10.16	Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016 (Businesswire)
10.10.16	Pfizer: Positive Results From SUTENT Trial As Adjuvant Therapy In Renal Cancer (RTTNews)
09.10.16	Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® (axitinib) In Advanced Renal Cell Carcinoma (RCC) (Businesswire)
06.10.16	ICU Medical To Acquire Pfizer's Hospira In $1 Bln Deal - Quick Facts (RTTNews)
28.09.16	Pfizer Completes Acquisition Of Medivation (RTTNews)
28.09.16	Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress (Businesswire)
26.09.16	Pfizer Says Not To Pursue Splitting Innovative Health, Essential Health Into Two (RTTNews)
23.09.16	Pfizer Gets U.S. Regulatory Approval For Medivation Takeover (RTTNews)
16.09.16	Pfizer Receives Positive CHMP Opinion For IBRANCE (RTTNews)
16.09.16	Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe (Businesswire)
15.09.16	OncoImmune Reaches Option And License Agreement With Pfizer (RTTNews)
15.09.16	Merck, Pfizer Announce Ertugliflozin Meets Primary Endpoint In Phase 3 Study (RTTNews)
15.09.16	Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz (RTTNews)
01.09.16	CYNA Snapped Up For $624 Mln, AMRN On Track, Genmab Gets FDA Nod (RTTNews)
31.08.16	XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer (Businesswire)
25.08.16	HEB Gets Some Respite, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN (RTTNews)
24.08.16	Pfizer Acquires Rights Of AstraZeneca's Small Molecule Anti-infectives Business (RTTNews)
23.08.16	Jacobs Wins Contract For Pfizer Global Biotechnology Center In China (RTTNews)
23.08.16	BPMX Scores A Facelift, MDVN Says "I Do" To PFE, Europe Gets Its 1st HIV PrEP (RTTNews)
22.08.16	Pfizer To Buy Prostate-cancer Drug Maker Medivation For $14 Bln (RTTNews)
22.08.16	Pfizer To Buy Medivation For Total Enterprise Value Of About $14 Bln (RTTNews)
22.08.16	Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation (RTTNews)
22.08.16	PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move (RTTNews)
22.08.16	Pfizer Reportedly Nears Agreement To Buy Medivation For About $14 Bln (RTTNews)
09.08.16	MESO Gains After Hours, PFNX Gets It Back, CHRS' Humira Biosimilar Meets Goals (RTTNews)
08.08.16	Pfizer Announces Publication Of New Data From Studies Of Vyndaqel - Quick Facts (RTTNews)
02.08.16	Pfizer Q2 Profit Beats Estimates; Standalone Revenues Up 4%; Reaffirms Guidance (RTTNews)
02.08.16	Pfizer Inc. Q2 Income Advances 10% (RTTNews)
02.08.16	SMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX (RTTNews)
01.08.16	Pfizer Buys Bamboo Therapeutics (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	237.10	1.80 %	K V
ABB	42.20	1.44 %	K V
Nestle	87.98	1.36 %	K V
Swiss Re	141.80	1.18 %	K V
CieFinRichemont	136.90	1.00 %	K V
Sika	195.55	-0.23 %	K V
Lonza Grp	539.20	-0.44 %	K V
Alcon	75.38	-0.48 %	K V
Holcim	87.62	-0.88 %	K V
Geberit	551.20	-1.29 %	K V

mehr

10:02		SMI-Titel Novartis-Aktie: So viel Gewinn hätte ein Novartis-Investment von vor 3 Jahren abgeworfen
10:02		DAX 40-Papier Merck-Aktie: So viel hätte eine Investition in Merck von vor 5 Jahren abgeworfen
18.04.25		Bayer-Aktie: Bayer-Chef erwägt mögliches Aus für Glyphosat in den USA
18.04.25		DAX 40-Wert Bayer-Aktie: So viel Verlust hätte ein Bayer-Investment von vor 3 Jahren eingebracht
17.04.25		GSK-Aktie dennoch tiefer: GSK-Impfstoffe erhalten grünes Licht vom US-Impfkomitee
17.04.25		EVOTEC-Aktie zieht kräftig an: EVOTEC erfüllt Jahresprognose 2024 trotz rückläufigem Ergebnis
16.04.25		Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Verlust hätte ein Johnson Johnson-Investment von vor 3 Jahren eingebracht
15.04.25		Johnson & Johnson steigert in Q1 Umsatz und Gewinn - Aktie leichter

10:02

SMI-Titel Novartis-Aktie: So viel Gewinn hätte ein Novartis-Investment von vor 3 Jahren abgeworfen

10:02

DAX 40-Papier Merck-Aktie: So viel hätte eine Investition in Merck von vor 5 Jahren abgeworfen

18.04.25

Bayer-Aktie: Bayer-Chef erwägt mögliches Aus für Glyphosat in den USA

18.04.25

DAX 40-Wert Bayer-Aktie: So viel Verlust hätte ein Bayer-Investment von vor 3 Jahren eingebracht

17.04.25

GSK-Aktie dennoch tiefer: GSK-Impfstoffe erhalten grünes Licht vom US-Impfkomitee

17.04.25

EVOTEC-Aktie zieht kräftig an: EVOTEC erfüllt Jahresprognose 2024 trotz rückläufigem Ergebnis